对于急性髓性白血病患者药物反应的强有力的预测因素
1Institute for Systems Biology, Seattle, Washington, United States of America.
PloS one
|February 23, 2026
概括
预测急性髓性白血病 (AML) 药物反应是非常重要的,因为患者的变化. 我们的新型k-Top Scoring Pairs (kTSP) 方法非常出色,特别是在不平衡的数据中,提供了强大的单个患者分类.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
背景情况:
- 急性髓性白血病 (AML) 在治疗结果中表现出显著的患者对患者的变化.
- 在AML中准确预测药物反应对于个性化医学至关重要.
研究的目的:
- 开发和评估用于预测AML患者药物反应的新计算方法.
- 将开发的k-Top分数对 (kTSP) 分类器的性能与现有的最先进的机器学习技术进行比较.
主要方法:
- 开发k-Top评分对 (kTSP) 分类器,一种集成方法,聚合相对基因对表达.
- 对kTSP与线性和辐射基础函数支持向量机器,随机森林和弹性净回归分类器进行比较分析.
- 评估分类器的性能,特别是在类分布不平衡的场景中.
主要成果:
- 与其他评估方法相比,kTSP分类器在预测AML药物反应方面表现出卓越的准确性.
- kTSP在处理不平衡数据集方面表现特别强,这是临床AML研究中常见的问题.
- 基于等级的kTSP方法为批量效应提供了固有的稳定性,并适合单个患者分类.
结论:
- kTSP提供了一种强大而准确的方法,用于预测急性髓性白血病的药物反应.
- 该方法在不平衡的数据集中的表现及其适用于单个患者分类的适用性解决了临床应用中的关键挑战.
- kTSP代表了针对个性化AML治疗策略的计算工具的宝贵进步.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.8K
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
849
相关概念视频
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
45
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
45
Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
